Production (Stage)
MAIA Biotechnology, Inc.
MAIA
$1.80
-$0.15-7.69%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.23M | 2.04M | 1.52M | 1.76M | 1.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.43M | 5.00M | 4.19M | 3.82M | 3.95M |
| Operating Income | -5.43M | -5.00M | -4.19M | -3.82M | -3.95M |
| Income Before Tax | -4.52M | -3.57M | -2.74M | -8.88M | -8.07M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.52M | -3.57M | -2.74M | -8.88M | -8.07M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.52M | -3.57M | -2.74M | -8.88M | -8.07M |
| EBIT | -5.43M | -5.00M | -4.19M | -3.82M | -3.95M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.16 | -0.14 | -0.11 | -0.40 | -0.46 |
| Normalized Basic EPS | -0.10 | -0.09 | -0.07 | -0.25 | -0.29 |
| EPS Diluted | -0.16 | -0.14 | -0.11 | -0.40 | -0.46 |
| Normalized Diluted EPS | -0.10 | -0.09 | -0.07 | -0.25 | -0.29 |
| Average Basic Shares Outstanding | 27.70M | 25.04M | 23.90M | 22.20M | 17.60M |
| Average Diluted Shares Outstanding | 27.70M | 25.04M | 23.90M | 22.20M | 17.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |